Home › Geographic Atrophy › Indiana
Geographic Atrophy clinical trials in Indiana
4 studies for Geographic Atrophy are looking for participants at sites in Indiana.
Cities in Indiana
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Midwest Eye Institute, Carmel
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Nov 5, 2026 · NCT06541704A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Midwest Eye Institute, Carmel
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Nov 3, 2026 · NCT06635148Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Partners Midwest, P.C., Carmel
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Partners Midwest, P.C. /ID# 262172, Carmel
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Jul 13, 2026 · NCT07160179From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.